- MyIllumina
- Tools
-
Access a broad range of molecular testing applications
Unmatched versatility in both multiplexing levels and assay applications
Read More » -
Featured Publication
"A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease" Mefford at al., Genome Res 19(9).
Read More or browse other publications»
-
Powered by VeraCode Technology
Robust detection for multiplex assays requiring high precision, accuracy, and speed
Learn More » -
See how customers are using BeadXpress
Jimmy Twin of Royal Women's Hospital in Melbourne wins Illumina's VeraCode Technology research challenge.
View the Presentation»
Get BeadXpress Updates
Join the conversation
Keep up-to-date with the latest online conversation surrounding BeadXpress.
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.